Latest updates, from us and our ventures
Q3 2019
#TB to our first ever #Leapstalk at #TOA19. Biotech, Health & the Era of Fast Capital with @ErikaMCheung and… https://t.co/CQ39veoOG6
— Leaps by Bayer (@LeapsByBayer) August 23, 2019
#MyocardialInfarction causes life-threatening damage to the heart. But #stemcell biologist Dr Ban Kiwon, of… https://t.co/WGomxpBXaj
— Leaps by Bayer (@LeapsByBayer) August 22, 2019
Monoclonal antibodies are a mainstay of modern medicine when fighting the likes of lupus and cancer. But how did th… https://t.co/IbSfOHt3hh
— Leaps by Bayer (@LeapsByBayer) August 21, 2019
Russian microbiologist, Denis Rebrikov, wants to follow in He Jianku’s footsteps and do what most scientists and ex… https://t.co/Sy9iJhlgxi
— Leaps by Bayer (@LeapsByBayer) August 12, 2019
The app 'Streams' by @DeepMindAI has provided the first hints that using #AI might be a much better way of assessin… https://t.co/AUKEdSlVn7
— Leaps by Bayer (@LeapsByBayer) August 09, 2019
RT @BayerPharma: The acquisition of @BlueRockTx manifests our successful innovation strategy with @LeapsByBayer to create biotechnological…
— Leaps by Bayer (@LeapsByBayer) August 08, 2019
This just in: With @BlueRockTx‘s industry-leading #iPSCs platform, we are thrilled to continue the journey towards… https://t.co/MzIpTsZuMd
— Leaps by Bayer (@LeapsByBayer) August 08, 2019
RT @BayerPharma: #NEWS: #Bayer will build leading position in cell therapy and acquires @BlueRockTx #CellTherapy #Innovation #StemCells…
— BlueRock (@BlueRockTx) August 08, 2019
We are pleased to announce that one of our founding investors, @BayerPharma, is building a leading position in… https://t.co/nmJVEcaWWB
— BlueRock (@BlueRockTx) August 08, 2019
A momentous occasion as the first study to test #CRISPR technology inside the human body is about to begin in the U… https://t.co/YYZm41GhtF
— Leaps by Bayer (@LeapsByBayer) August 08, 2019
Of 500 Americans involved in a 2-part study about #GMOs, 90% opposed their use. The same people also scored the low… https://t.co/D0u3GRuXXa
— Leaps by Bayer (@LeapsByBayer) August 07, 2019
54% of Americans believe the public should play an important role in guiding policy decisions on scientific issues,… https://t.co/LX1r27kvVX
— Leaps by Bayer (@LeapsByBayer) August 05, 2019
This week our #MissionBay team had a great summer outing and #teambuilding event at @HandsonGourmet in… https://t.co/zI4vasIjbm
— Casebia Therapeutics (@casebiatx) August 02, 2019
Dr. Gordon Keller, received the prestigious #OgawaYamanaka Stem Cell Prize for his work in stem cell biology and re… https://t.co/O33AThDHpK
— BlueRock (@BlueRockTx) August 02, 2019
As part of our “Casebia Coast to Coast Backpack Drive” our Mission Bay and Cambridge teams had the opportunity to f… https://t.co/UkzNzQ5rD9
— Casebia Therapeutics (@casebiatx) August 01, 2019
Our first ever #LeapsTalk features @ErikaMCheung and @SethBannon unpacking some of the ethical issues we're facing… https://t.co/r5LT8jjHLZ
— Leaps by Bayer (@LeapsByBayer) July 31, 2019
In a new effort to expand their research on plant microbes and nitrogen fixation, @joynbio have partnered with… https://t.co/LXR4lKrKOP
— Leaps by Bayer (@LeapsByBayer) July 30, 2019
Swedish researchers led by @EdwinWHJager of @liu_universitet have developed a new fabric that can be knitted and we… https://t.co/wF69CCcgcg
— Leaps by Bayer (@LeapsByBayer) July 26, 2019
While the mini organoids grown by @MCRI_for_kids cannot yet replace kidneys, they’re helping unlock the full potent… https://t.co/lDtKz5CJtr
— Leaps by Bayer (@LeapsByBayer) July 24, 2019
We’re proud to share that @RobinWalker will be speaking on two panels at this week’s @ACI_Pharma's Women Leaders i… https://t.co/whmg1eDtYm
— Casebia Therapeutics (@casebiatx) July 23, 2019
With plans to seek FDA approval to start clinical trials with humans next year, @neuralink claims that millions of… https://t.co/LTTrXfphe9
— Leaps by Bayer (@LeapsByBayer) July 22, 2019
Peter Nell, Ph.D., @CasebiaTx's SVP, Head of Corporate Strategy and Business Development, is featured in this excel… https://t.co/Va1jGmoEfw
— Casebia Therapeutics (@casebiatx) July 19, 2019
We’re backing @PyxisOncology in developing breakthroughs to fight cancer. Pyxis uses new understanding of a tumor's… https://t.co/8CoRHiibM0
— Leaps by Bayer (@LeapsByBayer) July 17, 2019
RT @BosBizJournal: Local biotechs UniQure, Casebia step up race for new hemophilia drugs https://t.co/Gao2CSVaQ8 https://t.co/zVu928WWHm
— Casebia Therapeutics (@casebiatx) July 12, 2019
Senior Scientist Keith Abe from our #MissionBay office will be speaking next week at the @ACDbio Symposium in… https://t.co/toNwz5bRVZ
— Casebia Therapeutics (@casebiatx) July 12, 2019
Of those included in genome-wide association studies of 2018, only 10% were Asian, 2% African, 1% Hispanic and less… https://t.co/X5PcMHsHfK
— Leaps by Bayer (@LeapsByBayer) July 12, 2019
Next week on July 16th, our SVP and Head of Technical Operations Stephen Kennedy will be speaking on the topic of '… https://t.co/RP7b7Jla68
— Casebia Therapeutics (@casebiatx) July 11, 2019
Did you know cells can talk to each other? Now, scientists can record them communicating in real time, allowing for… https://t.co/xD22gfQCPu
— Leaps by Bayer (@LeapsByBayer) July 10, 2019
A successful @ISTH 2019 Congress including a presentation by @CasebiaTx Principal Scientist Alan Brooks on 'Therape… https://t.co/P212PGTnhj
— Casebia Therapeutics (@casebiatx) July 08, 2019
Breaking news: @CasebiaTx highlights novel #research in #geneediting therapeutics for #hemophiliaA; early-stage ani… https://t.co/dY0fbDqOyJ
— Casebia Therapeutics (@casebiatx) July 08, 2019
Researchers at the @templemedschool and @unmc have pooled together in a groundbreaking collaboration to successfull… https://t.co/WINSxfQEXT
— Leaps by Bayer (@LeapsByBayer) July 08, 2019
'There are 17,100,000 deaths from cardiovascular disease each year in the USA. That's 300 people gone since I start… https://t.co/Mo9FcXftQ2
— Leaps by Bayer (@LeapsByBayer) July 05, 2019
The first #LeapsTalk featured Theranos whistleblower and molecular biologist @ErikaMCheung. Erika is the co-founder… https://t.co/yKbnAak6FZ
— Leaps by Bayer (@LeapsByBayer) July 05, 2019
Head of Leaps by Bayer, Jürgen Eckhardt, kicking off the first ever #LeapsTalk yesterday with @ErikaMCheung,… https://t.co/XSbjAeEjV5
— Leaps by Bayer (@LeapsByBayer) July 05, 2019
Our first ever #LeapsTalk takes place @TOABerlin: Biotech, Health & the Era of Fast Capital. We explore what we can… https://t.co/xtfcBOLUFT
— Leaps by Bayer (@LeapsByBayer) July 04, 2019
#HappyFourth from all of us at Casebia! https://t.co/gYDG6M1OSr
— Casebia Therapeutics (@casebiatx) July 03, 2019
We’re partnering with @century_tx to develop curative therapies for cancer using #iPSCs. Learn more here:… https://t.co/EoXlohsNeL
— Leaps by Bayer (@LeapsByBayer) July 01, 2019